Spots Global Cancer Trial Database for A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)
Official Title: A Phase 3, Multicenter, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)
Study ID: NCT03217812
Conditions
Study Description
Brief Summary: The purpose of this study is to determine if the addition of daratumumab to VELCADE-melphalan-prednisone (VMP) will improve very good partial response (VGPR) or better compared with VMP alone.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Chaoyang Hospital, Beijing, , China
Peking Union Medical College Hospital, Beijing, , China
Peking University First Hospital, Beijing, , China
Beijing Chaoyang Hospital, Beijing, , China
Peking University Third Hospital, Beijing, , China
The First Hospital of Jilin University, Changchun, , China
The Third Xiangya Hospital, Central South University, Changsha, , China
West China Hospital Si Chuan University, Chengdu, , China
Second Affiliated Hospital of Army Medical University, Chongqing, , China
Fujian Meidical University Union Hospital, Fuzhou, , China
Guangdong Provincial People's Hospital, Guangzhou, , China
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, , China
Nanfang Hospital, Guangzhou, , China
First Affiliated Hospital Medical School of Zhejiang University, Hangzhou, , China
First affiliated Hospital of Zhejiang University, Hangzhou, , China
Harbin medical university cancer hospital, Harbin, , China
Nanjing Drum Tower Hospital, Nanjing, , China
Zhongda Hospital Southeast University, Nanjing, , China
Jiangsu Province Hospital, Nanjing, , China
Shanghai Changzheng Hospital, Shanghai, , China
Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, , China
Shanghai Zhongshan Hospital, Shanghai, , China
Renji Hospital, Shanghai Jiaotong University School of Medicine, ShangHai, , China
First Affiliated Hospital SooChow University, Suzhou, , China
Tianjin cancer hospital, Tianjin, , China
Institute of Hematology and Blood Diseases Hospital, Tianjin, , China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, , China
Tongji Hospital, Tongji Medical College of HUST, Wuhan, , China
Tangdu Hospital, Xian, , China
Henan Cancer Hospital, Zhengzhou, , China
Queen Mary Hospital University of Hong Kong, Hong Kong, , Hong Kong
Inje University Busan Paik Hospital, Busan, , Korea, Republic of
Gachon University Gil Medical Center, Incheon, , Korea, Republic of
Chonnam National University Hwasun Hospital, Jeollanam-do, , Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, , Korea, Republic of
Ulsan University Hospital, Ulsan, , Korea, Republic of
Hospital Ampang, Ampang, , Malaysia
Hospital Pulau Pinang, George Town, , Malaysia
Hospital Queen Elizabeth, Kota Kinabalu, , Malaysia
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Chang Gung Memorial Hospital, Taoyuan, , Taiwan
Contact Details
Name: Janssen Research & Development, LLC Clinical Trial
Affiliation: Janssen Research & Development, LLC
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
